Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study
American journal of preventive cardiology, 2026;27:101521
Anti-Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea
Chronic diseases and translational medicine, 2026;12(2):100-112
Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells
Journal of proteome research, 2026;25(4):2084-2097
Glucagon-Like Peptide-1 Receptor Agonists Improve Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction, Independent of Diabetes: A Systematic Review and Meta-Analysis
CJC open, 2026;8(6):646-654
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review
Pharmaceuticals (Basel, Switzerland), 2026;19(2)
Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications
International journal of molecular sciences, 2026;27(4)
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias
Pharmaceuticals (Basel, Switzerland), 2026;19(2)
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats
Pharmaceuticals (Basel, Switzerland), 2026;19(1)
Decidualization-empowered ECM hydrogel integrating sustained Tβ4 release drives endometrial regeneration in intrauterine adhesions
Nature communications, 2026;17(1)
Thymosin beta 4: An emerging therapeutic candidate for kidney diseases
Peptides, 2026;195:171467
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats
Pharmaceuticals (Basel, Switzerland), 2026;19(1)
Anxiolytic Effect of GHK-PGP Peptide and Its Structural Analogues in a Test with Punished Behavior
Bulletin of experimental biology and medicine, 2026;179(5):575-578
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026;10(1)
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
The American journal of sports medicine, 2026;54(1):223-229
Smart Healing for Wound Repair: Emerging Multifunctional Strategies in Personalized Regenerative Medicine and Their Relevance to Orthopedics
Antibiotics (Basel, Switzerland), 2026;15(1)
A revised model of nuclear actin import: Importin 9 competes with cofilin, profilin, and RanGTP for actin binding
The Journal of biological chemistry, 2025;302(2):111123
Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 × FAD mice: A potential therapy for memory improvement in Alzheimer’s disease
International immunopharmacology, 2025;170:116097
Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins’ activity for fascia regeneration
Journal of controlled release : official journal of the Controlled Release Society, 2025;390:114521
Thymosin β4 stabilizes hypoxia induced brain microvascular endothelial cell dysfunction through S1PR1 dependent mechanisms
Scientific reports, 2025;15(1):45764
Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy
Pharmaceuticals (Basel, Switzerland), 2025;18(12)